ALLO, NasdaqGS
Allogene Therapeutics, Inc. (ALLO)
Price (as of October 24)
9.75USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Entasis Therapeutics Holdings Inc. |
-0.4 |
|
Novavax, Inc. |
-0.35 |
|
NRx Pharmaceuticals, Inc. |
-0.31 |
|
Stealth BioTherapeutics Corp |
-0.31 |
|
Spruce Biosciences, Inc. |
-0.31 |
|
Eton Pharmaceuticals, Inc. |
-0.04 |
|
Sorrento Therapeutics, Inc. |
-0.02 |
|
TRACON Pharmaceuticals, Inc. |
-0.04 |
|
Tenaya Therapeutics, Inc. |
0.04 |
|
VectivBio Holding AG |
0.03 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
ALX Oncology Holdings Inc. |
0.6 |
|
Arcturus Therapeutics Holdings Inc. |
0.58 |
|
Arrowhead Pharmaceuticals, Inc. |
0.57 |
|
Ascendis Pharma A/S |
0.57 |
|
Arvinas, Inc. |
0.56 |
|
Alpine Immune Sciences, Inc. |
0.12 |
|
AnaptysBio, Inc. |
0.1 |
|
Aptevo Therapeutics Inc. |
0.18 |
|
Annexon, Inc. |
0.24 |
|
Alnylam Pharmaceuticals, Inc. |
0.28 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Xeris Biopharma Holdings, Inc. |
-0.18 |
|
Iterum Therapeutics plc |
-0.17 |
|
CRISPR Therapeutics AG |
-0.17 |
|
Cullinan Oncology, Inc. |
-0.17 |
|
F-star Therapeutics, Inc. |
-0.16 |
|
Crinetics Pharmaceuticals, Inc. |
-0.03 |
|
Puma Biotechnology, Inc. |
-0.09 |
|
Calithera Biosciences, Inc. |
-0.07 |
|
CTI BioPharma Corp. |
-0.05 |
|
Oramed Pharmaceuticals Inc. |
-0.1 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
ALX Oncology Holdings Inc. |
0.67 |
|
Arrowhead Pharmaceuticals, Inc. |
0.6 |
|
Arcturus Therapeutics Holdings Inc. |
0.58 |
|
Arvinas, Inc. |
0.57 |
|
Ardelyx, Inc. |
0.51 |
|
Ascendis Pharma A/S |
0.28 |
|
AlloVir, Inc. |
0.28 |
|
Assembly Biosciences, Inc. |
0.2 |
|
AnaptysBio, Inc. |
0.1 |
|
argenx SE |
0.31 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Opthea Limited |
-0.14 |
|
Arcellx, Inc. |
-0.14 |
|
Caribou Biosciences, Inc. |
-0.13 |
|
Imago BioSciences, Inc. |
-0.1 |
|
Pasithea Therapeutics Corp. |
-0.1 |
|
Oramed Pharmaceuticals Inc. |
-0.1 |
|
Mind Medicine (MindMed) Inc. |
-0.09 |
|
Immix Biopharma, Inc. |
-0.09 |
|
Puma Biotechnology, Inc. |
-0.09 |
|
Vaxxinity, Inc. |
-0.09 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.35 |
|
ALX Oncology Holdings Inc. |
0.35 |
|
argenx SE |
0.31 |
|
Arvinas, Inc. |
0.29 |
|
AlloVir, Inc. |
0.28 |
|
Arcutis Biotherapeutics, Inc. |
0.28 |
|
Applied Molecular Transport Inc. |
0.28 |
|
Alnylam Pharmaceuticals, Inc. |
0.28 |
|
Ascendis Pharma A/S |
0.28 |
|
Apellis Pharmaceuticals, Inc. |
0.28 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Opthea Limited |
-0.14 |
|
Arcellx, Inc. |
-0.14 |
|
Caribou Biosciences, Inc. |
-0.13 |
|
Imago BioSciences, Inc. |
-0.1 |
|
Pasithea Therapeutics Corp. |
-0.1 |
|
Oramed Pharmaceuticals Inc. |
-0.1 |
|
Mind Medicine (MindMed) Inc. |
-0.09 |
|
Immix Biopharma, Inc. |
-0.09 |
|
Puma Biotechnology, Inc. |
-0.09 |
|
Vaxxinity, Inc. |
-0.09 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.35 |
|
ALX Oncology Holdings Inc. |
0.35 |
|
argenx SE |
0.31 |
|
Arvinas, Inc. |
0.29 |
|
AlloVir, Inc. |
0.28 |
|
Arcutis Biotherapeutics, Inc. |
0.28 |
|
Applied Molecular Transport Inc. |
0.28 |
|
Alnylam Pharmaceuticals, Inc. |
0.28 |
|
Ascendis Pharma A/S |
0.28 |
|
Apellis Pharmaceuticals, Inc. |
0.28 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Entasis Therapeutics Holdings Inc. |
-0.4 |
|
Tilray Brands, Inc. |
-0.36 |
|
Novavax, Inc. |
-0.35 |
|
KORU Medical Systems, Inc. |
-0.32 |
|
NRx Pharmaceuticals, Inc. |
-0.31 |
|
Stealth BioTherapeutics Corp |
-0.01 |
|
Spruce Biosciences, Inc. |
0.03 |
|
Eton Pharmaceuticals, Inc. |
-0.04 |
|
So-Young International Inc. |
-0.03 |
|
Sorrento Therapeutics, Inc. |
-0.02 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
ALX Oncology Holdings Inc. |
0.6 |
|
Arcturus Therapeutics Holdings Inc. |
0.58 |
|
Arrowhead Pharmaceuticals, Inc. |
0.57 |
|
Ascendis Pharma A/S |
0.57 |
|
ANI Pharmaceuticals, Inc. |
0.57 |
|
Arvinas, Inc. |
0.29 |
|
Alpine Immune Sciences, Inc. |
0.12 |
|
AnaptysBio, Inc. |
0.1 |
|
Aptevo Therapeutics Inc. |
0.18 |
|
American Well Corporation |
0.32 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Inspira Technologies Oxy B.H.N. Ltd. |
-0.36 |
|
ReWalk Robotics Ltd. |
-0.29 |
|
CareDx, Inc |
-0.22 |
|
AmerisourceBergen Corporation |
-0.18 |
|
Xeris Biopharma Holdings, Inc. |
-0.18 |
|
Chembio Diagnostics, Inc. |
0.02 |
|
CareMax, Inc. |
-0.11 |
|
Iterum Therapeutics plc |
-0.03 |
|
CRISPR Therapeutics AG |
-0.02 |
|
Cullinan Oncology, Inc. |
-0.07 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
ALX Oncology Holdings Inc. |
0.67 |
|
Arrowhead Pharmaceuticals, Inc. |
0.6 |
|
Arcturus Therapeutics Holdings Inc. |
0.58 |
|
Arvinas, Inc. |
0.57 |
|
Ardelyx, Inc. |
0.51 |
|
Ascendis Pharma A/S |
0.28 |
|
American Well Corporation |
0.32 |
|
AlloVir, Inc. |
0.28 |
|
Assembly Biosciences, Inc. |
0.2 |
|
AnaptysBio, Inc. |
0.1 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Inspira Technologies Oxy B.H.N. Ltd. |
-0.35 |
|
Opthea Limited |
-0.14 |
|
Mainz Biomed B.V. |
-0.14 |
|
Arcellx, Inc. |
-0.14 |
|
AmerisourceBergen Corporation |
-0.13 |
|
Caribou Biosciences, Inc. |
-0.13 |
|
Embecta Corp. |
-0.12 |
|
IceCure Medical Ltd |
-0.12 |
|
CareMax, Inc. |
-0.11 |
|
Bright Green Corporation |
-0.11 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.35 |
|
ALX Oncology Holdings Inc. |
0.35 |
|
American Well Corporation |
0.32 |
|
Apollo Medical Holdings, Inc. |
0.31 |
|
argenx SE |
0.31 |
|
Arvinas, Inc. |
0.29 |
|
AlloVir, Inc. |
0.28 |
|
Arcutis Biotherapeutics, Inc. |
0.28 |
|
Applied Molecular Transport Inc. |
0.28 |
|
Alnylam Pharmaceuticals, Inc. |
0.28 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Inspira Technologies Oxy B.H.N. Ltd. |
-0.35 |
|
Opthea Limited |
-0.14 |
|
Mainz Biomed B.V. |
-0.14 |
|
Arcellx, Inc. |
-0.14 |
|
AmerisourceBergen Corporation |
-0.13 |
|
Caribou Biosciences, Inc. |
-0.13 |
|
Embecta Corp. |
-0.12 |
|
IceCure Medical Ltd |
-0.12 |
|
CareMax, Inc. |
-0.11 |
|
Bright Green Corporation |
-0.11 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.35 |
|
ALX Oncology Holdings Inc. |
0.35 |
|
American Well Corporation |
0.32 |
|
Apollo Medical Holdings, Inc. |
0.31 |
|
argenx SE |
0.31 |
|
Arvinas, Inc. |
0.29 |
|
AlloVir, Inc. |
0.28 |
|
Arcutis Biotherapeutics, Inc. |
0.28 |
|
Applied Molecular Transport Inc. |
0.28 |
|
Alnylam Pharmaceuticals, Inc. |
0.28 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
ShotSpotter, Inc. |
-0.43 |
|
Entasis Therapeutics Holdings Inc. |
-0.4 |
|
Revelstone Capital Acquisition Corp. |
-0.38 |
|
First Horizon Corporation |
-0.37 |
|
Euroseas Ltd. |
-0.37 |
|
Full House Resorts, Inc. |
0.02 |
|
Tilray Brands, Inc. |
-0.05 |
|
JFrog Ltd. |
-0.06 |
|
Disruptive Acquisition Corporation I |
-0.01 |
|
Phoenix New Media Limited |
0.02 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Genomic Revolution ETF |
0.69 |
|
ALX Oncology Holdings Inc. |
0.6 |
|
Arcturus Therapeutics Holdings Inc. |
0.58 |
|
Arrowhead Pharmaceuticals, Inc. |
0.57 |
|
Pacer Lunt Large Cap Alternator ETF |
0.57 |
|
Ascendis Pharma A/S |
0.28 |
|
ANI Pharmaceuticals, Inc. |
0.25 |
|
ARK Autonomous Technology & Robotics ETF |
0.42 |
|
PROSHARES MSCI TRANSFORMATIONAL CHANGES ETF |
0.36 |
|
Arvinas, Inc. |
0.29 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Maquia Capital Acquisition Corporation |
-0.41 |
|
Inspira Technologies Oxy B.H.N. Ltd. |
-0.36 |
|
Lytus Technologies Holdings PTV. Ltd. |
-0.35 |
|
Silver Spike Acquisition Corp II |
-0.33 |
|
Valor Latitude Acquisition Corp. |
-0.32 |
|
Population Health Investment Co., Inc. |
-0.03 |
|
Priveterra Acquisition Corp. |
-0.13 |
|
ReWalk Robotics Ltd. |
-0.06 |
|
The OLB Group, Inc. |
-0.05 |
|
NetScout Systems, Inc. |
-0.13 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Genomic Revolution ETF |
0.68 |
|
ALX Oncology Holdings Inc. |
0.67 |
|
ARK Autonomous Technology & Robotics ETF |
0.62 |
|
Arrowhead Pharmaceuticals, Inc. |
0.6 |
|
Arcturus Therapeutics Holdings Inc. |
0.58 |
|
Arvinas, Inc. |
0.29 |
|
ARK Space Exploration & Innovation ETF |
0.39 |
|
PROSHARES MSCI TRANSFORMATIONAL CHANGES ETF |
0.36 |
|
First Trust IndxxMetaverse ETF |
0.56 |
|
Arrival |
0.3 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Maquia Capital Acquisition Corporation |
-0.38 |
|
Lytus Technologies Holdings PTV. Ltd. |
-0.35 |
|
Inspira Technologies Oxy B.H.N. Ltd. |
-0.35 |
|
Silver Spike Acquisition Corp II |
-0.27 |
|
Investcorp Europe Acquisition Corp I |
-0.24 |
|
Forafric Global PLC |
-0.23 |
|
Metal Sky Star Acquisition Corporation |
-0.22 |
|
Valor Latitude Acquisition Corp. |
-0.2 |
|
Jaguar Global Growth Corporation I |
-0.2 |
|
BondBloxx B-Rated USD High Yield Corporate Bond ETF |
-0.2 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
First Trust IndxxMetaverse ETF |
0.56 |
|
AI Quality Growth ETF |
0.51 |
|
ARK Genomic Revolution ETF |
0.49 |
|
Model Performance Acquisition Corp. |
0.43 |
|
ARK Autonomous Technology & Robotics ETF |
0.42 |
|
ARK Space Exploration & Innovation ETF |
0.39 |
|
iShares Core Aggressive Allocation ETF |
0.36 |
|
iShares Core Growth Allocation ETF |
0.36 |
|
PROSHARES MSCI TRANSFORMATIONAL CHANGES ETF |
0.36 |
|
Arrowhead Pharmaceuticals, Inc. |
0.35 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Maquia Capital Acquisition Corporation |
-0.38 |
|
Lytus Technologies Holdings PTV. Ltd. |
-0.35 |
|
Inspira Technologies Oxy B.H.N. Ltd. |
-0.35 |
|
Silver Spike Acquisition Corp II |
-0.27 |
|
Investcorp Europe Acquisition Corp I |
-0.24 |
|
Forafric Global PLC |
-0.23 |
|
Metal Sky Star Acquisition Corporation |
-0.22 |
|
Valor Latitude Acquisition Corp. |
-0.2 |
|
Jaguar Global Growth Corporation I |
-0.2 |
|
BondBloxx B-Rated USD High Yield Corporate Bond ETF |
-0.2 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
First Trust IndxxMetaverse ETF |
0.56 |
|
AI Quality Growth ETF |
0.51 |
|
ARK Genomic Revolution ETF |
0.49 |
|
Model Performance Acquisition Corp. |
0.43 |
|
ARK Autonomous Technology & Robotics ETF |
0.42 |
|
ARK Space Exploration & Innovation ETF |
0.39 |
|
iShares Core Aggressive Allocation ETF |
0.36 |
|
iShares Core Growth Allocation ETF |
0.36 |
|
PROSHARES MSCI TRANSFORMATIONAL CHANGES ETF |
0.36 |
|
Arrowhead Pharmaceuticals, Inc. |
0.35 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL. The company also develops ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A, which is in Phase I/II clinical trial for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-819, an allogeneic CAR T cell product candidates for the treatment of acute myeloid leukemia; and DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc., as well as clinical trial collaboration agreement with SpringWorks Therapeutics, Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates. The company was incorporated in 2017 and is headquartered in South San Francisco, California.